基本信息
浏览量:60
职业迁徙
个人简介
Francois is co-founder and CEO at Shape Therapeutics. Prior to ShapeTX, Francois co-founded AbVitro with Harvard Medical School Professor George Church, where he pioneered the development of high throughput immune single-cell sequencing. AbVitro was acquired by Juno Therapeutics where Francois became VP of Research until its acquisition by Celgene and shortly after by Bristol-Myers Squibb. Francois completed a postdoctoral Fellow in George Church’s lab at Harvard Medical School and holds a Ph.D. in Molecular Biology, as well as a BA in microbiology from Laval University, Quebec, Canada. Francois also served for a decade as a Maritime Warfare Officer (MARS) in the Canadian Navy.
研究兴趣
论文共 65 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
D. J. Huss, T. A. Packard, E. Cates, M. Lee, J. E. Bazinet, K. C. Stein, Y. Jiang, M. F. L. Andrade, T. J. Long,F. Vigneault, R. Hause,A. W. Briggs
HUMAN GENE THERAPYno. 23-24 (2022): A32-A33
引用0浏览0引用
0
0
引用0浏览0引用
0
0
Frontiers in immunology (2019): 1516-1516
加载更多
作者统计
#Papers: 65
#Citation: 3374
H-Index: 29
G-Index: 58
Sociability: 6
Diversity: 0
Activity: 0
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn